About: Food Intake and Energy Homeostasis Pathway

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Food Intake and Energy Homeostasis Pathway Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	Food Intake and Energy Homeostasis Pathway
rdfs:subClassOf	Metabolic Pathway Homeostasis Regulation Pathway
Semantic_Type	Functional Concept
Preferred_Name	Food Intake and Energy Homeostasis Pathway
UMLS_CUI	C1517287
BioCarta_ID	h_ghrelinPathway
ALT_DEFINITION	The synthesis and release of growth hormone (GH) from the pituitary are controlled by the hypothalamic hormones GH-releasing hormone (GHRH) and somatostatin (SRIF), which in turn are regulated by feedback from blood GH and insulin-like growth factor-I (IGF-I) concentrations. The recently discovered endogenous GH-releasing peptide, called ghrelin, also stimulates GH release. Circulating GH acts directly on many organs to stimulate IGF-I production, with IGF-I production in the liver providing the main source of blood IGF-I. Most of the IGF-I in the circulation is bound to IGF-binding protein-3 (IGFBP-3) in a ternary complex with acid-labile subunit (ALS); a smaller fraction is bound to the five other IGFBP. A small fraction of the total IGF-I in blood is in a bioactive-free fraction. In the kidney, IGF-I increases renal plasma flow and GFR, whereas on bone it acts on the epiphysial plate, which leads to longitudinal bone growth. GH also has direct effects on many organs, including kidney and cartilage, which can be independent of IGF-I action. The GH/IGF-I axis in chronic renal failure (CRF) is changed markedly compared with the normal axis. In CRF, the total concentrations of the hormones in the GH/IGF-I axis are not reduced, but there is reduced effectiveness of endogenous GH and IGF-I, which probably plays a major role in reducing linear bone growth. The reduced effectiveness of endogenous IGF-I likely is due to decreased levels of free, bioactive IGF-I as levels of circulating inhibitory IGFBP are increased. In addition, less IGF-I is circulating in the complex with ALS and IGFBP-3 as a result of increased proteolysis of IGFBP-3. Together, these lead to decreased IGF-I receptor activation and a decreased feedback to the hypothalamus and pituitary. Low free IGF-I and high IGFBP-1 and -2 levels probably contribute to a reduced renal function and lead to a reduced stature. The direct effects of GH on bone, which are poorly understood, also are blunted.BIOCARTA
Legacy_Concept_Name	Food_Intake_and_Energy_Homeostasis_Pathway
FULL_SYN	Ghrelin: Regulation of Food Intake and Energy HomeostasisPTBIOCARTA Food Intake and Energy Homeostasis PathwayPTNCI
code	C39093
is someValuesFrom of	nodeID://b675114 nodeID://b675122 nodeID://b677721 nodeID://b677729 nodeID://b681218 nodeID://b681242 nodeID://b681247 nodeID://b681254 nodeID://b681261 nodeID://b681267 nodeID://b681273 nodeID://b682744 nodeID://b682796 nodeID://b682803 nodeID://b682807 nodeID://b682813 nodeID://b682819 nodeID://b682823 nodeID://b711078 nodeID://b713302

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 122 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software